End Price Gouging for Medications Act
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in senate (Jun 26, 2019)
End Price Gouging for Medications Act
This bill requires the Department of Health and Human Services (HHS) to set maximum prices for prescription drugs under specified federal health programs. Specifically, HHS must establish reference prices based on certain factors, including drug prices in listed countries. Retail prices of covered drugs under specified federal health programs (e.g., Medicare and Medicaid) may not exceed the established reference prices. Drugs must also be available at such prices to uninsured individuals and to individuals with private health insurance.
What just happenedJun 26, 2019
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S4569-4570)
Who’s behind it
- Introduced in SenateJun 26, 2019
- Jun 26, 2019IntroReferral
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S4569-4570)
Health, Education, Labor, and Pensions Committee - Jun 26, 2019IntroReferral10000
Introduced in Senate